ClearPoint Neuro, Inc.·4

Mar 5, 4:48 PM ET

BURNETT JOSEPH 4

4 · ClearPoint Neuro, Inc. · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
BURNETT JOSEPH
DirectorCEO and President
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-03+26,56839,067 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-03$8.84/sh9,533$84,27229,534 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1]
    2026-03-0326,568106,273 total
    Common Stock (26,568 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: See Footnote)
    193,231
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
  • [F2]Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
  • [F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett|2026-03-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4